Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Effects of Ciclesonide MDI 50mg/Day and 200mg/Day (Ex-Valve) Once-Daily on Growth in Children With Mild Persistent Asthma

This study has been completed.
Sponsor:
Collaborator:
Takeda
Information provided by:
Sanofi
ClinicalTrials.gov Identifier:
NCT00270348
First received: December 22, 2005
Last updated: December 27, 2005
Last verified: December 2005
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Estimated Study Completion Date: September 2004
  Estimated Primary Completion Date: No date given
No publications provided by Sanofi

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):